Accession Number: | 0000819050-21-000091 |
Date: | 2021-06-14 |
Issuer: | BRICKELL BIOTECH, INC. (BBI) |
Original Submission Date: |
BRETON JOSE
C/O BRICKELL BIOTECH, INC.
5777 CENTRAL AVENUE, SUITE 102
BOULDER, CO 80301
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 0.9 | 2021-06-14 | deemed execution date | A | 85,000 (a) | 2022-06-14 | 2031-06-14 | common stock 85,000 | $0.90 | 85,000 | direct |
ID | footnote |
---|---|
f1 | the stock options will vest 25% on june 14, 2022, and the remainder will vest in equal monthly installments over the following three years. |